X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Packaging & Logistic

Airnov to exhibit range of healthcare packaging solutions to Indian market at Innopack Pharma Confex-South

Content Team by Content Team
1st August 2022
in Packaging & Logistic, Press Statements
Airnov to exhibit range of healthcare packaging solutions to Indian market at Innopack Pharma Confex-South

Airnov Healthcare Packaging, a global leader in controlled atmosphere packaging, will be showcasing its large portfolio of solutions available to customers in India at the upcoming Innopack Pharma Confex-South, due to be held in the city of Hyderabad on August 9-10.

The event marks an extension of the already highly successful and influential Innopack series, which is now meeting in Hyderabad to offer more industry stakeholders the chance to see and hear from the best minds on what’s next in the world of pharma packaging.

Here, Airnov will be demonstrating a range of value-add capabilities.

Chief among them is Stablus, a predictive modelling and simulation tool. Stablus helps customers determine optimal solutions for shelf-life protection within key cost parameters.

Airnov’s line of desiccant canisters and packets are designed for high-speed automatic insertion in customers’ packaging lines. This ensures seamless integration with existing manufacturing setups, with our engineers also on hand to provide technical support when needed.

The company will also be showing visitors at Innopack Pharma Confex-South, the Compatilus program, which ensures full compatibility with various automatic desiccant inserters for drop-in desiccants available from key equipment manufacturers.

By evaluating how packaging configurations impacts relative humidity levels and/ oxygen concentrations inside packaging across its lifecycle, customers will be able to identify technical and cost-saving improvements and reduce time to market for new products.

Airnov will also be showcasing a series of physical pioneering packaging solutions. These include EQius™ Equilibrium RH Stabilizers – these are sorbent products that maintain a certain humidity level in pharmaceutical packaging in cases where specific relative humidity conditions are required. In particular, these are solutions aimed at dry powder inhalers, gelatin capsules and gummies.

Shrikar Trikannad, Airnov’s Head of Sales for India, commented: “After a successful Innopack event in Mumbai in June, we are equally excited to head to Hyderabad, where our highly experienced team will be on hand and ready to answer any questions about any of our solutions and services.”

Visitors will also be able to learn more about our product development and innovation workshops. Whether it’s tweaking a standard product or developing a design for a customized packaging system, Airnov has a full product development team that will quickly and efficiently engineer a solution.

“With a 65-year legacy to build on and three dedicated R&D centers, we remain at the forefront of research into materials and designs that will shape the future of healthcare packaging” concludes Trikannad.

During the Innopack Pharma Confex-South, which is being hosted at the Novotel HICC, Airnov will be situated in Booth 2A.

Previous Post

Automated Dried Spot Sampling and Analysis System Redefines Workflow

Next Post

Authorities Agree To Work Together Towards Integrating RWE

Related Posts

Avadel Pharmaceuticals Receives
Drug Development

Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

9th June 2025
ACHEMA
Middle East and South Asia

ACHEMA Middle East to Debut in Riyadh in 2026 Trade Show

9th May 2025
Press Statements

APM Steam Highlights Comprehensive HVAC Insulation Services for Biopharmaceutical and Pharmaceutical Facilities

19th April 2025
Healthcare Packaging
Asia

Amcor Healthcare Packaging Expansion in Asia Pacific

16th April 2025
Americas

Thermo Fisher to acquire Solventum’s Purification & Filtration business for US$4.1bn

4th March 2025
Drug Development

Celonic Group Signs Long-Term Multi-Year Manufacturing Service Agreement with LINDIS Biotech for the Commercial Supply of Catumaxomab

4th March 2025
Next Post
Authorities Agree To Work Together Towards Integrating RWE

Authorities Agree To Work Together Towards Integrating RWE

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In